ベインのウェブサイトは、ユーザーの、利便性の向上、と機能改善のために、クッキーを使用しています。詳細は、弊社のプライバシーポリシーをご参照ください。このサイト閲覧を継続されることで、クッキーの使用についてご了承いただいたことになります。

ケーススタディ

Review focuses biotech on portfolio potential

This biotech client was managing a complex product portfolio with significant revenue but only breakeven profitability. Bain performed a comprehensive portfolio review that resulted in clear project-level recommendations to refocus the company's resources on projects with the highest potential.

  • min read

全文

The Situation

  • BiotechCo* is a research-based pharmaceutical company that develops and commercializes drugs in several therapeutic areas
  • BiotechCo has several products on the market and about a dozen in different stages of development
  • The company has significant revenue from royalties and marketed products, with breakeven profitability
  • BiotechCo's drug portfolio is increasingly complex and difficult to manage
  • Public pressure is being applied by investors calling for strategic moves to jolt the stock out of its current range

 

Our Approach

Combine strategic priorities with project and process evaluation:

Our Recommendations

Review the highest-priority opportunities for strategic fit:

The Results

Refocus resources on highest potential projects:

 

* We take our clients' confidentiality seriously. While we've changed their names, the results are real. 

お気軽にご連絡下さい

私達は、グローバルに活躍する経営者が抱える最重要経営課題に対して、厳しい競争環境の中でも成長し続け、「結果」を出すために支援しています。